In an additional mouse model of RTT, a truncation of MeCP2 at amino acid 308 (MeCP2308/Y) leads to a less severe progression of neurological phenotypes but also mirrors deficits found in RTT patients. This evidence concerns the gene MECP2 and Rett syndrome.